Press Release Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients with Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial 8 September 2024
Press Release Ivonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in China 8 September 2024
Press Release Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024 8 September 2024
Press Release Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs) 8 September 2024
Press Release Day 2 of 11th Annual World Patient Safety, Science & Technology Summit Highlights Importance of Collaboration and Advanced Technologies 8 September 2024
Press Release Aon and Marsh McLennan Call on (Re)insurance Industry to Aid Ukraine’s Resilience 8 September 2024
Press Release Boll & Branch’s Most Luxurious Fabric Debuts on the Runway at Prabal Gurung’s NYFW Show 7 September 2024
Press Release ESGR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enstar Group Limited Is Fair to Shareholders 7 September 2024
Press Release GigCapital7 Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing September 10, 2024 6 September 2024
